benzonaphtho<2,3-e><1,4>dioxin-6,11-quinone | 118210-25-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: benzonaphtho<2,3-e><1,4>dioxin-6,11-quinone
• 英文别名: Benzonaphtho<2,3-e>dioxine-6,11-dione；benzo[b]dibenzo[b,e][1,4]dioxine-6,11-dione；benzo[b]naphtho[2,3-e][1,4]dioxin-6,11-dione；Benzo[b]naphtho[2,3-e][1,4]dioxin-6,11-dion；benzo[b]oxanthrene-6,11-dione
• CAS: 118210-25-6
• 化学式: C₁₆H₈O₄
• 分子量: 264.237
• InChiKey: LCEQMUPOBPPCOJ-UHFFFAOYSA-N

物化性质

• 熔点：
  290 °C
• 沸点：
  386.0±42.0 °C(Predicted)
• 密度：
  1.49±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  20
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  二(三甲基硅基)碳酰二亚胺 、 benzonaphtho<2,3-e><1,4>dioxin-6,11-quinone 在 四氯化钛 作用下， 以 二氯甲烷 为溶剂， 以72%的产率得到(6-Cyanoiminobenzo[b]oxanthren-11-ylidene)cyanamide
  参考文献：
  名称：

  Synthesis and electrochemical properties of benzo[b]naphtho[2,3-e][1,4]-dioxin-6,11-quinones and their N,N'-dicyano quinone diimine derivatives

  摘要：

  The reaction of 2,3-dichloro-1,4-naphthoquinone (1) and catechols 2 in pyridine affords a series of substituted benzo[b]naphtho[2,3-e][1,4]dioxin-6,11-quinones 3. The latter compounds are transformed to the corresponding N,N'-dicyano quinone diimines 4, by treating them with N,N'-bis(trimethylsilyl)carbodiimide. The electrochemical studies of compounds of the type 3 and 4 in DMF and CH2Cl2, respectively, by means of cyclic voltammetry are reported. The experimental reduction potentials provide information on electron-electron repulsion in the dianionic states of 3 and 4, and hence on their potential use as acceptor components in charge-transfer complexes and organic conductors.

  DOI：

  10.1021/jo00004a042
• 作为产物：
  描述：

  2,3-二氯-1,4-萘醌 、 邻苯二酚 在 吡啶 作用下， 反应 6.0h， 以69%的产率得到benzonaphtho<2,3-e><1,4>dioxin-6,11-quinone
  参考文献：
  名称：

  Synthesis and electrochemical properties of benzo[b]naphtho[2,3-e][1,4]-dioxin-6,11-quinones and their N,N'-dicyano quinone diimine derivatives

  摘要：

  The reaction of 2,3-dichloro-1,4-naphthoquinone (1) and catechols 2 in pyridine affords a series of substituted benzo[b]naphtho[2,3-e][1,4]dioxin-6,11-quinones 3. The latter compounds are transformed to the corresponding N,N'-dicyano quinone diimines 4, by treating them with N,N'-bis(trimethylsilyl)carbodiimide. The electrochemical studies of compounds of the type 3 and 4 in DMF and CH2Cl2, respectively, by means of cyclic voltammetry are reported. The experimental reduction potentials provide information on electron-electron repulsion in the dianionic states of 3 and 4, and hence on their potential use as acceptor components in charge-transfer complexes and organic conductors.

  DOI：

  10.1021/jo00004a042

文献信息

• Water-promoted unprecedented chemoselective nucleophilic substitution reactions of 1,4-quinones with oxygen nucleophiles in aqueous micelles
  作者：Vishnu K. Tandon、Hardesh K. Maurya

  DOI：10.1016/j.tetlet.2010.05.071

  日期：2010.7

  Unique nucleophilic substitution and addition reactions of nitrogen and sulfur nucleophiles with 1,4-quinones in aqueous suspension with amines and thiols have recently been demonstrated by us.2 However, the reactivity of oxygen nucleophiles toward nucleophilic substitution compared to nitrogen and sulfur nucleophiles ‘on water’ is not facile. An unprecedented economical, green methodology approach

  最近我们已经证明了氮和硫亲核体与1，4-醌在胺和硫醇的水悬浮液中的独特亲核取代和加成反应。2然而，与“在水上”的氮和硫亲核试剂相比，氧亲核试剂对亲核取代的反应性并不容易。已经证明了一种空前的经济，绿色方法学方法，该方法使用普通洗衣粉（LD；洗衣粉，0.5 mol％，可重复使用）/ SDS作为表面活性剂“在水中”，以优异的产率被1,4-醌中的氧亲核试剂亲核取代。
• Use of small molecule compounds for immunopotentiation
  申请人：Valiante M. Nicholas

  公开号：US20050136065A1

  公开（公告）日：2005-06-23

  The invention provides immunostimulatory compositions comprising a small molecule immuno-poteniator (SMIP) compound and methods of administration thereof. Also provided are methods of administering a SMIP compound in an effective amount to enhance the immune response of a subject to an antigen. Further provided are novel compositions and methods of administering SMIP compounds alone or in combination with another agent for the treatment of cancer, infectious diseases and/or allergies/asthma.

  本发明提供了包含小分子免疫增强剂（SMIP）化合物的免疫刺激组合物及其给药方法。还提供了在有效剂量下给予SMIP化合物以增强受体对抗原的免疫反应的方法。此外，还提供了用于治疗癌症、传染性疾病和/或过敏/哮喘的新型组合物和给药SMIP化合物的方法，单独或与另一种药物联合使用。
• Severe acute respiratory syndrome coronavirus
  申请人：Rappuoli Rino

  公开号：US20060257852A1

  公开（公告）日：2006-11-16

  An outbreak of a virulent respiratory virus, now known as Severe Acute Respiratory Syndrome (SARS), was identified in Hong Kong, China and a growing number of countries around the world in 2003. The invention relates to nucleic acids and proteins from the SARS coronavirus. These nucleic acids and proteins can be used in the preparation and manufacture of vaccine formulations, diagnostic reagents, kits, etc. The invention also provides methods for treating SARS by administering small molecule antiviral compounds, as well as methods of identifying potent small molecules for the treatment of SARS.

  2003年，在中国香港和世界各地越来越多的国家中，爆发了一种名为严重急性呼吸综合症（SARS）的致命呼吸道病毒。本发明涉及来自SARS冠状病毒的核酸和蛋白质。这些核酸和蛋白质可以用于制备和制造疫苗配方、诊断试剂盒等。本发明还提供了通过给予小分子抗病毒化合物治疗SARS的方法，以及识别用于治疗SARS的有效小分子的方法。
• Use of organic compounds for immunopotentiation
  申请人：Novartis Vaccines and Diagnostics, Inc.

  公开号：EP2258365A1

  公开（公告）日：2010-12-08

  The invention provides immunostimulatory compositions comprising a small molecule immuno-poteniator (SMIP) compound and methods of administration thereof. Also provided are methods of administering a SMIP compound in an effective amount to enhance the immune response of a subject to an antigen. Further provided are novel compositions and methods of administering SMIP compounds alone or in combination with another agent for the treatment of cancer, infectious diseases and/or allergies/asthma.

  本发明提供了包含小分子免疫增强剂（SMIP）化合物的免疫刺激组合物及其施用方法。还提供了施用有效量的 SMIP 化合物以增强受试者对抗原的免疫应答的方法。此外，还提供了单独施用 SMIP 化合物或与另一种制剂联合施用 SMIP 化合物以治疗癌症、传染性疾病和/或过敏/哮喘的新型组合物和方法。
• Small molecule immunopotentiators and assays for their detection
  申请人：Novartis Vaccines and Diagnostics, Inc.

  公开号：EP2583678A2

  公开（公告）日：2013-04-24

  The invention provides immunostimulatory compositions comprising a small molecule immuno-potentiator (SMIP) compound and methods of administration thereof. Also provided are methods of administering a SMIP compound in an effective amount to enhance the immune response of a subject to an antigen. Further provided are novel compositions and methods of administering SMIP compounds alone or in combination with another agent for the treatment of cancer, infectious diseases and/or allergies/asthma. In a further aspect, the invention relates generally to methods of screening for small molecule immuno-modulatory compositions.

  本发明提供了包含小分子免疫促进剂（SMIP）化合物的免疫刺激组合物及其施用方法。还提供了施用有效量的 SMIP 化合物以增强受试者对抗原的免疫应答的方法。本发明还提供了单独施用 SMIP 化合物或与另一种制剂联合施用 SMIP 化合物以治疗癌症、传染性疾病和/或过敏/哮喘的新型组合物和方法。在另一方面，本发明一般涉及筛选小分子免疫调节组合物的方法。